Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers April 2013

Editorial

Dear Opalesque Reader,

Welcome to the April 2013 issue of New Managers, Opalesque's monthly monitor of new, emerging and re-emerging alternative fund managers.

Following the Emanagers Index performance for March and this month's list of new funds in the EManagers database, is an analysis produced by our research unit on the performance of funds that invest in currencies in EManagers DB Insights.

In Focus, we look at the way hedge funds tend to use social media (part 1), K&L Gates' recommendations on social media best practices (part 2), and the main drivers for hedge funds to engage in social media (part 3) as seen by Henrietta Hirst of Parex PR. This month's 47N series, "Barbarians at the Gate", tells you all about investor-level gates. Stephen Tirrell of Bingham McCutchen talks about the current legal landscape for those looking to raise funds in the U.S. in Rules and Regulations. We reveal the latest developments for Mariner, NewAlpha, IMQ and Scout Global in Seeders' Corner News Review. And Apex Fund Services explains its new free office facilities and fund incubation services in Servicers' Spot.

This month's report ends with the customary recapitulation of recent maiden fund Launches and related matters, a review of the latest news, views and findings relevant to the emerging fund space in News & Perspectives. And in Profiles, Theron de Ris talks about the Eschler Recovery Fund; and Louis Fortin and Francois Magny talk about RDA Capital's Mons Regalis Multi-Strategy LP.

Don't forget, as a subscriber, you can access past issues of New Managers in our Archive here: http://www.opalesque.com/Archive-New-Managers.html.......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for